Nuvectis Pharma NVCT - Options Chain | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Nuvectis Pharma Inc (NVCT)
Nuvectis Pharma Inc (NVCT) Options

Nuvectis Pharma Inc (NVCT)

8.865

0.165

(1.90%)

Closed 19 April 6:00AM

Delayed by 15 minutes

8.865

0.00

(0.00%)

After Hours: 6:48AM

Delayed by 15 minutes

NVCT Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	4.90	9.00	0.00	6.95	0.00	0.00 %	0	0	-
5.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
7.50	1.60	3.70	2.20	2.65	0.00	0.00 %	0	20	-
10.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
12.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
15.00	0.05	4.90	1.05	2.475	0.00	0.00 %	0	12	-
17.50	0.00	4.90	0.00	0.00	0.00	0.00 %	0	0	-

Empower your portfolio: Real-time discussions and actionable trading ideas.

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
5.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
7.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
10.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
12.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
15.00	5.70	8.80	0.00	7.25	0.00	0.00 %	0	0	-
17.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MSGMMotorsport Games Inc	US$ 2.69 (140.18%)	37M
SXTCChina SXT Pharmaceuticals Inc	US$ 2.11 (113.37%)	51.73M
ADGMAdagio Medical Holdings Inc	US$ 1.68 (81.98%)	115.48M
PNBKPatriot National Bancorp Inc	US$ 3.28 (73.54%)	1.57M
RTCBaijiayun Group Ltd	US$ 0.3601 (67.49%)	187.02M
LXEHLixiang Education Holding Company Ltd	US$ 8.25 (-64.11%)	1.55M
CLIKClick Holdings Ltd	US$ 0.355 (-48.18%)	13.52M
IOTRiOThree Ltd	US$ 1.1409 (-38.33%)	3.93M
FMTOFemto Technologies Inc	US$ 0.0191 (-35.47%)	198.4M
SISIShineco Inc	US$ 0.5809 (-35.07%)	824.91k
DMNDamon Inc	US$ 0.0034 (9.68%)	409.39M
STSSSharps Technology Inc	US$ 0.03195 (20.57%)	391.8M
SUNESUNation Energy Inc	US$ 0.0176 (-10.20%)	349.4M
NVDANVIDIA Corporation	US$ 101.49 (-2.87%)	292.48M
HTZHertz Global Holdings Inc	US$ 8.205 (43.70%)	266.91M

gail

gail 5 months ago

grabbed some on the dip

Monksdream

Monksdream 7 months ago

Monksdream

Monksdream 9 months ago

Monksdream

Monksdream 12 months ago

Monksdream

Monksdream 1 year ago

NVCT 10Q due March 6

Monksdream

Monksdream 1 year ago

conix

conix 3 years ago

NVCT HIGHLIGHTS:

*Recently completed Initial Public Offering - $5.00 Per share
*2 Precision Cancer medicines in development - ovarian and triple negative breast
*Data flow throughout 2022
*CEO with multiple success stories in life science sector to $billion dollar market caps
*Analysts project a $66 billion precision medicines market for 2021; In 6 years, this number is expected to top $140 billion

Nuvectis Pharma Inc - Company Background:

Nuvectis Pharma, Inc. is a biopharmaceutical company focused on the development of innovative precision medicines for serious conditions of unmet medical need in oncology. The Company is currently developing two drug candidates: NXP800, a clinical-stage HSF1 pathway inhibitor currently in a Phase 1 study in patients with advanced solid tumors, and NXP900, a novel SRC/YES1 kinase inhibitor currently in preclinical development with IND-enabling studies ongoing.

Market Capitalization: $225 million
Range - 52 week: $3.08 - $20.75
Current Price: $20.44
Trades on: Nasdaq Capital Market
Ticker Symbol: NVCT

website: nuvectis.com

TheFinalCD

TheFinalCD 3 years ago

wow from $3 to almost $21

ipo_dude

ipo_dude 3 years ago

TheFinalCD

TheFinalCD 3 years ago

WOW $7 MOVE 3-10

CONGRAT$ NVCT

spindog

spindog 3 years ago

I feel the same

kkballa

kkballa 3 years ago

Nuvectis Pharma

iShare Trust iShares ESG...

La Banque Postale 2% 13j...

Electricite de France SA...

First Trust II First Tru...

Ares Lusitani Domestic b...

Westport Fuel Systems

Invesco Nasdaq Biotechno...

Heartland Financial USA

Minco Capital (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions